WELCOME TO OUR PARKINSON'S PLACE!

I HAVE PARKINSON'S DISEASES AND THOUGHT IT WOULD BE NICE TO HAVE A PLACE WHERE THE CONTENTS OF UPDATED NEWS IS FOUND IN ONE PLACE. THAT IS WHY I BEGAN THIS BLOG.

I COPY NEWS ARTICLES PERTAINING TO RESEARCH, NEWS AND INFORMATION FOR PARKINSON'S DISEASE, DEMENTIA, THE BRAIN, DEPRESSION AND PARKINSON'S WITH DYSTONIA. I ALSO POST ABOUT FUNDRAISING FOR PARKINSON'S DISEASE AND EVENTS. I TRY TO BE UP-TO-DATE AS POSSIBLE.

I AM NOT RESPONSIBLE FOR IT'S CONTENTS. I AM JUST A COPIER OF INFORMATION SEARCHED ON THE COMPUTER. PLEASE UNDERSTAND THE COPIES ARE JUST THAT, COPIES AND AT TIMES, I AM UNABLE TO ENLARGE THE WORDING OR KEEP IT UNIFORMED AS I WISH. IT IS IMPORTANT TO UNDERSTAND I AM A PERSON WITH PARKINSON'S DISEASE. I HAVE NO MEDICAL EDUCATION,

I JUST WANT TO SHARE WITH YOU WHAT I READ ON THE INTERNET. IT IS UP TO YOU TO DECIDE WHETHER TO READ IT AND TALK IT OVER WITH YOUR DOCTOR. I AM JUST THE COPIER OF DOCUMENTS FROM THE COMPUTER. I DO NOT HAVE PROOF OF FACT OR FICTION OF THE ARTICLE. I ALSO TRY TO PLACE A LINK AT THE BOTTOM OF EACH ARTICLE TO SHOW WHERE I RECEIVED THE INFORMATION SO THAT YOU MAY WANT TO VISIT THEIR SITE.

THIS IS FOR YOU TO READ AND TO ALWAYS KEEP AN OPEN MIND.

PLEASE DISCUSS THIS WITH YOUR DOCTOR, SHOULD YOU HAVE ANY QUESTIONS, OR CONCERNS. NEVER DO ANYTHING WITHOUT TALKING TO YOUR DOCTOR FIRST..

I DO NOT MAKE ANY MONEY FROM THIS WEBSITE. I VOLUNTEER MY TIME TO HELP ALL OF US TO BE INFORMED.

I WILL NOT ACCEPT ANY ADVERTISEMENT OR HEALING POWERS, HEALING FROM HERBS AND ETC. UNLESS IT HAS GONE THROUGH TRIALS AND APPROVED BY FDA. IT WILL GO INTO SPAM.

THIS IS A FREE SITE FOR ALL WITH NO ADVERTISEMENTS

THANK YOU FOR VISITING! TOGETHER WE CAN MAKE A DIFFERENCE!

TRANSLATE

Saturday, May 24, 2014

PRAMIPEXOLE CLINICAL TRIAL RESULTS IN PARKINSON'S DISEASE

20th May 2014 - New research

Barone, Y.Mizuno, O.Rascol, M.Busse, C.Debieuvre, M.Fraessdorf, W.Poewe
European Journal of Neurology [2014] 21 (5) : 736-743 (R.A.Hauser, A.H.Schapira, P.
Barone,Complete abstract : http://www.ncbi.nlm.nih.gov/pubmed/24834511
The long term safety and efficacy of pramipexole was assessed as an extended-release oral
formulation and immediate release formulation in early or advanced Parkinson's Disease.
Pramipexole, which is marketed as Mirapex, Mirapexin, and Sifrol, is a dopamine agonist.
For more information go to Pramipexole : http://www.rxlist.com/mirapex-drug.htm
In those people with early Parkinson's Disease the reported side
effects were somnolence (15%), peripheral edema (11%) and back
pain (10%). The scores on the Parkinson's Disease symptom score
(UPDRS) after over 2 years were down by 6.6 when using extended
release pramipexole and 6.3 when using immediate release
pramipexole. In those people with advanced Parkinson's Disease the
reported side effects were dyskinesia (27%), somnolence (13%),
and impulse control disorders (1%). The scores on the Parkinson's
Disease symptom score (UPDRS) after over 2 years were down by
11.5 when using extended release pramipexole and 9.1 when using
immediate release pramipexole.
In both early and advanced Parkinson's Disease better efficacy was achieved when using the
extended release version of pramipexole. The adverse events were typical for dopaminergic
drugs.
©2014 Viartis

No comments:

Post a Comment